Kalpesh V. Upadhye

With a background in physics and life sciences, Kalpesh has experience with subject matter in a wide variety of technical areas that intersect technology and life sciences, including biomaterials, drug delivery, biosensors, bioreactors, medical devices, semiconductors, photovoltaics, electronic and electromechanical components, lighting systems, telecommunications, navigation systems, autonomous vehicle systems, batteries, engineered materials, bulk metallic glasses, meta materials, magnetoresistive materials, and superconductors, as well as biotechnology.

Prior to joining Morgan Lewis, Kalpesh worked as a patent agent with another major general practice law firm. During his postdoctoral research, Kalpesh developed nonviral methods for nucleotide delivery into mammalian cells. Kalpesh’s doctoral thesis focused on the multiparametric investigation of mechanosensitive ion channels in mammalian cells and developing the tools required for such multiparametric investigation. Previously, Kalpesh developed MEMS-based point-of-care sensors for measuring cardiac markers in human blood for early diagnosis of myocardial infarction.

Kalpesh received his J.D. from the George Washington University Law School in 2019. Kalpesh has been a member of the patent bar since 2012. He is fluent in Hindi and Marathi.

• Conducted patent prosecution for a Korean university for gene therapy and bioreactors
• Conducted patent prosecution for a British university for hybrid adenoviral vectors
• Conducted patent prosecution for a US university for antimicrobial compositions and gene therapy
• Drafted patents and conducted prosecution for a California-based biopharmaceutical company for method of treatment with viral-based gene therapy
• Conducted gene therapy patent landscape analysis for a California-based biopharmaceutical company